摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-bromo-3-(isopropylamino)pyrazin-2-ol | 510771-53-6

中文名称
——
中文别名
——
英文名称
6-bromo-3-(isopropylamino)pyrazin-2-ol
英文别名
5-Bromo-2-(N-isopropylamino)-3-hydroxypyrazine;6-bromo-3-(propan-2-ylamino)-1H-pyrazin-2-one
6-bromo-3-(isopropylamino)pyrazin-2-ol化学式
CAS
510771-53-6
化学式
C7H10BrN3O
mdl
——
分子量
232.08
InChiKey
NDUVZXAXDRQDFB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    53.5
  • 氢给体数:
    2
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-bromo-3-(isopropylamino)pyrazin-2-olN,N'-羰基二咪唑 以91%的产率得到6-bromo-3-isopropyl[1,3]oxazolo[4,5-b]pyrazin-2(3H)-one
    参考文献:
    名称:
    Synthesis of a versatile 2 (1H)-pyrazinone core for the preparation of Tissue Factor-Factor VIIa inhibitors
    摘要:
    A new, general synthetic route to 2(1H)-pyrazinones 11 is described The four-step synthesis is accomplished utilizing a regioselective hydrolysis and N-alkylation These compounds efficiently undergo metal-catalyzed cross-coupling reactions to install P2 diversity groups in the 6-position, which can be used to refine the SAR of the S2 pocket of the Tissue Factor/Factor VIIa (TF/VIIa) complex (C) 2010 Elsevier Ltd All rights reserved
    DOI:
    10.1016/j.tet.2010.02.026
  • 作为产物:
    描述:
    3,5-dibromo-N-isopropylpyrazin-2-amine 、 potassium hydroxide 作用下, 反应 20.0h, 以87%的产率得到6-bromo-3-(isopropylamino)pyrazin-2-ol
    参考文献:
    名称:
    Synthesis of a versatile 2 (1H)-pyrazinone core for the preparation of Tissue Factor-Factor VIIa inhibitors
    摘要:
    A new, general synthetic route to 2(1H)-pyrazinones 11 is described The four-step synthesis is accomplished utilizing a regioselective hydrolysis and N-alkylation These compounds efficiently undergo metal-catalyzed cross-coupling reactions to install P2 diversity groups in the 6-position, which can be used to refine the SAR of the S2 pocket of the Tissue Factor/Factor VIIa (TF/VIIa) complex (C) 2010 Elsevier Ltd All rights reserved
    DOI:
    10.1016/j.tet.2010.02.026
点击查看最新优质反应信息

文献信息

  • Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade
    申请人:Pharmacia Corporation
    公开号:US20040082585A1
    公开(公告)日:2004-04-29
    The present invention relates to prodrug compounds, compositions and methods useful for preventing and treating thrombotic conditions in mammals. The prodrug compounds of the present invention selectively inhibit certain proteases of the coagulation cascade.
    本发明涉及一种用于预防和治疗哺乳动物血栓性疾病的前药化合物、组合物和方法。本发明的前药化合物选择性地抑制凝血级联反应中的某些蛋白酶
  • 6-MEMBERED UNSATURATED HETEROCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OFTHE COAGULATION CASCADE
    申请人:Pharmacia Corporation
    公开号:EP1448534A1
    公开(公告)日:2004-08-25
  • PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE
    申请人:Pharmacia Corporation
    公开号:EP1482940A2
    公开(公告)日:2004-12-08
  • [EN] PRODRUGS OF SUBSTITUTED POLYCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE<br/>[FR] PROMEDICAMENTS DE COMPOSES POLYCYCLIQUES SUBSTITUES UTILES POUR L'INHIBITION SELECTIVE DE LA CASCADE DE LA COAGULATION
    申请人:PHARMACIA CORP
    公开号:WO2003028729A2
    公开(公告)日:2003-04-10
    The present invention relates to prodrug compounds, comprising a 5- or 6- membered heterocyclic or aromatic ring substituted with a derivatized amidine, as well as compositions and methods useful for preventing and treating thrombotic conditions in mammals. The prodrug compounds of the present invention selectively inhibit certain proteases of the coagulation cascade.
  • [EN] 6-MEMBERED UNSATURATED HETEROCYCLIC COMPOUNDS USEFUL FOR SELECTIVE INHIBITION OF THE COAGULATION CASCADE<br/>[FR] COMPOSES HETEROCYCLIQUES INSATURES A 6 CHAINONS UTILES POUR L'INHIBITION SELECTIVE DE REACTIONS EN CASCADE DE LA COAGULATION
    申请人:PHARMACIA CORP
    公开号:WO2003029224A1
    公开(公告)日:2003-04-10
    The present invention relates to compounds, and prodrugs thereof, composition and methods useful for preventing and treating thrombotic conditions in mammals. The compounds of the present invention, and prodrugs thereof, selectively inhibit certain proteases of the coagulation cascade.
查看更多